Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Manganese superoxide dismutase
(
Mn-SOD
) inactivates the radiation effect by removal of radiation-induced toxic superoxide radicals. The purpose of this study was to assess the correlation among
Mn-SOD
, radiation sensitivity, and prognosis following radiation therapy. The
Mn-SOD
, p53 oncoprotein, and c-
erbB-2
oncoprotein expressions in 52 specimens from patients with cervical cancer treated with radiation therapy were investigated immunohistochemically. The frozen sections were stained using antihuman
Mn-SOD
, anti-p53 monoclonal antibodies, and anti-c-
erbB-2
oncoprotein polyclonal antibody followed by the avidin-biotin peroxidase complex method. Correlations among
Mn-SOD
expression, prognosis, and failure patterns were analyzed. Additionally, correlations between p53 and c-
erbB-2
oncoproteins and
Mn-SOD
expression were investigated. Positive expression of
Mn-SOD
in cervical carcinoma was 48.1%. No significant difference in positivity of
Mn-SOD
expression was noted according to stage and histological subtypes. The 5-year survival rate of
Mn-SOD
-positive patients was 42.5 %, significantly poorer than the 77.0% of
Mn-SOD
-negative patients (P < 0.05). Analysis of the failure patterns revealed that patients with
Mn-SOD
expression showed a significantly higher incidence of local recurrence than those without. However, there was no difference in distant metastasis between them. Although both p53 and c-
erbB-2
oncoprotein expressions were significantly associated with the prognosis of the same patients,
Mn-SOD
expression was associated with p53 oncoprotein expression but not with that of c-
erbB-2
oncoprotein. Our results demonstrate that the
Mn-SOD
level of cancer cells is correlated with local control and is an important prognostic factor in radiation therapy for cervical cancer. The
Mn-SOD
level may help explain the intrinsic radiosensitivity of cervical cancer cells.
...
PMID:Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. 866 12